当前位置:首页 / 普罗布考、阿托伐他汀联合治疗颈动脉粥样硬化斑块临床疗效观察
论著 | 更新时间:2016-03-08
|
普罗布考、阿托伐他汀联合治疗颈动脉粥样硬化斑块临床疗效观察
Observations on clinical effects of probucol combined with atorvastatin in treating carotid atherosclerosis plaque

内科 201601期 页码:13-15+68

作者机构:甘肃省定西市第二人民医院神经内科,定西市743000

基金信息:

DOI:DOI:10.16121/j.cnki.cn45-1347/r.2016.01.05

  • 中文简介
  • 英文简介
  • 参考文献
目的探讨普罗布考、阿托伐他汀联合治疗颈动脉粥样硬化斑块的临床疗效。方法选取80例急性脑梗死、经颈部血管超声检查证实伴有颈动脉粥样硬化斑块的患者为研究对象,根据随机数字表法随机分为观察组和对照组,每组40例。两组患者均予降压、降糖、抗血小板聚集等常规治疗,在常规治疗基础上对照组患者加用阿托伐他汀钙、观察组患者加用阿托伐他汀钙以及普罗布考治疗,疗程6个月。观察比较两组患者治疗前后血脂、颈动脉内膜-中层厚度(IMT)、斑块长径及斑块厚度变化情况。结果观察组患者治疗总有效率(90.0%)显著高于对照组(70.0%),差异具有统计学意义(P<0.05)。治疗后两组患者的血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)较治疗前显著降低,高密度脂蛋白胆固醇(HDL-C)较治疗前显著升高,且观察组患者TC、TG及LDL-C显著低于对照组,HDL-C显著高于对照组(P<0.05);两组患者的IMT、斑块长径及斑块厚度较治疗前显著降低,且观察组IMT、斑块长径及斑块厚度显著低于对照组(P<0.05)。结论普罗布考、阿托伐他汀联合应用可以提高颈动脉粥样硬化斑块患者的临床疗效,更有效缩小斑块,值得临床推广应用。
ObjectiveTo investigate the clinical effect of probucol combined with atorvastatin in treating carotid atherosclerosis plaque. MethodsA total of 80 patients with cerebral infarction complicated with carotid atherosclerosis plaque were selected and randomly divided into observation group and control group,with 40 cases in each group. All patients received conventional treatment including antihypertensive, hypoglycemic, anti platelet aggregation etc, and control group was given atorvastatin on the basis of conventional treatment, while the observation group received probucol and atorvastatin on the basis of conventional treatment, the course of treatment was 6 months.Blood lipid,IMT, the length and thickness of the plaques between two groups were compared before and after treatment. ResultsThe total effective rate of the observation group (90%) was significantly higher than that of control group (70%, P<0.05). After treatment, IMT, the length and thickness of the plaques, the level of TC,TG, LDL-C in two groups were decreased significantly as compared with those before treatment, and the level of HDL-C was increased significantly as compared with that before treatment, and IMT, the length and thickness of the plaques, the level of TC,TG, LDL-C in observation group were significantly lower than those of control group, while the level of HDL-C was significantly higher than that of control group(P<0.05). ConclusionsProbucol combined with atorvastatin in treating carotid atherosclerosis plaque can increase therapeutic effect, reduced plaque, which is worth popularizing in clinical practice.

3017

浏览量

1214

下载量

0

CSCD

工具集